Literature DB >> 8479195

Immunohistologic analysis of the extracellular matrix components of the fibrous stroma of human colon cancer.

S Miura1, S Kodaira, Y Hosoda.   

Abstract

In order to elucidate the gross composition of fibrous stroma and to better understand the obstructive nature of advanced human colonic cancers the extracellular matrix components of its stroma were analyzed immunohistologically, emphasizing the process of fibrosis and possible tissue constriction. Collagenous material, identified by Masson's trichrome stain, was distributed mainly in the invasive area, where type I and III collagens and chondroitin 4-sulfate stained intensely in the periacinar area, and further, fibronectin stained. Conversely, in the invasive area away from tumor acini type III collagen stained weakly and fibronectin not at all. Type V collagen and myofibroblasts stained in the periacinar area and did not stain in the invasive area away from tumor acini, the findings of myofibroblasts being prominent in cases with obstructive type carcinomas. In conclusion, the invasive area, especially the periacinar area, displayed signs of active ongoing fibrosis and tissue contraction, which may be responsible for the genesis of obstructing type colonic carcinomas.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8479195     DOI: 10.1002/jso.2930530111

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  9 in total

1.  Labeling fibroblasts with biotin-BSA-GdDTPA-FAM for tracking of tumor-associated stroma by fluorescence and MR imaging.

Authors:  D Granot; L A Kunz-Schughart; M Neeman
Journal:  Magn Reson Med       Date:  2005-10       Impact factor: 4.668

2.  Desmoplasia in different degrees of invasion of carcinoma ex-pleomorphic adenoma.

Authors:  Vera Cavalcanti de Araújo; Cristiane Furuse; Patricia Ramos Cury; Albina Altemani; Venâncio Avancini Ferreira Alves; Ney Soares de Araújo
Journal:  Head Neck Pathol       Date:  2007-11-27

3.  Proliferation of myofibroblasts in the stroma of renal oncocytoma.

Authors:  T-H Yen; Y Chen; J-F Fu; C-H Weng; Y-C Tian; C-C Hung; J-L Lin; C-W Yang
Journal:  Cell Prolif       Date:  2010-04-14       Impact factor: 6.831

4.  Inhibition of Angiogenesis and Extracellular Matrix Remodeling: Synergistic Effect of Renin-Angiotensin System Inhibitors and Bevacizumab.

Authors:  Tianshu Ren; Hui Jia; Qiong Wu; Yan Zhang; Qun Ma; Dong Yao; Xudong Gao; Danni Xie; Zihua Xu; Qingchun Zhao; Yingshi Zhang
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

Review 5.  The role of fibroblasts in tumor behavior.

Authors:  M Grégoire; B Lieubeau
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

6.  Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis.

Authors:  Martin Köbel; Wilko Weichert; Katharina Crüwell; Wolfgang D Schmitt; Christine Lautenschläger; Steffen Hauptmann
Journal:  Virchows Arch       Date:  2004-09-16       Impact factor: 4.064

7.  Cellular localization, invasion, and turnover are differently influenced by healthy and tumor-derived extracellular matrix.

Authors:  Luca Genovese; Lidia Zawada; Antonella Tosoni; Angelita Ferri; Pietro Zerbi; Raffaele Allevi; Manuela Nebuloni; Massimo Alfano
Journal:  Tissue Eng Part A       Date:  2014-03-06       Impact factor: 3.845

8.  Efficacy of a novel auto-fluorescence imaging system with computer-assisted color analysis for assessment of colorectal lesions.

Authors:  Hiroko Inomata; Naoto Tamai; Hiroyuki Aihara; Kazuki Sumiyama; Shoichi Saito; Tomohiro Kato; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

9.  Spread of tumor microenvironment contributes to colonic obstruction through subperitoneal fibroblast activation in colon cancer.

Authors:  Mitsuru Yokota; Motohiro Kojima; Youichi Higuchi; Yuji Nishizawa; Akihiro Kobayashi; Masaaki Ito; Norio Saito; Atsushi Ochiai
Journal:  Cancer Sci       Date:  2015-03-19       Impact factor: 6.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.